Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with BayerGlobeNewsWire • Wednesday
Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor TechnologyGlobeNewsWire • 09/09/24
Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial OfficerGlobeNewsWire • 09/03/24
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 SalesGlobeNewsWire • 08/26/24
Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing DirectorGlobeNewsWire • 08/20/24
Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing RequirementsGlobeNewsWire • 08/06/24
Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScienceGlobeNewsWire • 08/02/24
Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM SensorGlobeNewsWire • 06/24/24
Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes AssociationGlobeNewsWire • 06/10/24
Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated TechnologyGlobeNewsWire • 06/03/24
Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAIGlobeNewsWire • 05/16/24
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV SalesGlobeNewsWire • 05/13/24
Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and DevelopmentGlobeNewsWire • 05/08/24
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business UpdatesGlobeNewsWire • 04/04/24
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price RuleGlobeNewsWire • 03/08/24